XML 39 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Equity | 6 Months Ended
--- | ---
Jun. 28, 2020
Equity [Abstract] |
Equity | Equity A. Preferred Stock Prior to May 4, 2020, Pfizer’s Series A convertible perpetual preferred stock (the Series A Preferred Stock) was held by an employee stock ownership plan trust (the Trust). All outstanding shares of Series A Preferred Stock were converted, at the direction of the independent fiduciary under the Trust and in accordance with the certificate of designations for the Series A Preferred Stock, into shares of Pfizer common stock on May 4, 2020. The Trust received an aggregate of 1,070,369 shares of Pfizer common stock upon conversion, with zero shares of Series A Preferred Stock remaining outstanding as a result of the conversion. B. Dividends
The following table summarizes quarterly cash dividends:
2020 |  | 2019
Date Declared |  | Payment Date |  | Dividend Per Share |  |  | Date Declared |  | Payment Date |  | Dividend Per Share |
December 13, 2019 |  | March 6, 2020 |  | 0.38 |  |  | December 14, 2018 |  | March 1, 2019 |  | 0.36 |
April 23, 2020 |  | June 5, 2020 |  | 0.38 |  |  | April 25, 2019 |  | June 7, 2019 |  | 0.36 |
June 25, 2020 |  | September 1, 2020 |  | 0.38 |  |  | June 27, 2019 |  | September 3, 2019 |  | 0.36 |
|  |  |  |  |  | September 24, 2019 |  | December 2, 2019 |  | 0.36 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration